Playlist Mode Print Mode Enable Media Only

News chronological

10 items before 1151641 (Keyword: "drug-development" (~35 currently found))

YOUTUBE (Fox Business) - Moderna cancer vaccine BREAKTHROUGH drives new hope after phase 3 trial

Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #trial #biotech #technology #treatment #breakthrough #healthcare #innovation

YOUTUBE (Fox Business) - New drug shows promise for lung cancer

Revolution Medicines CEO Dr. Mark Goldsmith discusses the clinical trial results from Rasonque on ‘FBN’s Wall Street.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #fbnswallstreet #markgoldsmith #goldsmith #revolutionmedicines #rasonque #cancer #cancertreatment #clinicaltrial #biotech #biotechnology #healthcare #medicalresearch #medicine #pharmaceuticals #investing

YOUTUBE (Newsmax) - Israeli Scientists Say Viagra Could Help Stop Cancer Spread | Israel Update (Sept. 3, 2026)

Could a common medication help fight cancer? And what are American tourists saying after returning to Israel? In today's NEWSMAX Israel Update, Katrina Szish reports on new research from Israeli scientists who say the active ingredient in Viagra may help prevent cancer from spreading. The findings were based on mouse cancer models and decades of research, with clinical trials identified as a possible next step. Then, correspondent Jodie Cohen speaks with American visitors in Tel Aviv and Hostages Square, where tourists share their reactions to returning to Israel and reflect on the country's resilience and recovery.

WASHINGTONPOST (Daniel Wu) - FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives

In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times for one of the deadliest cancers.

JUSTTHENEWS (Kevin Killough) - FDA approves pancreatic cancer drug that nearly doubles survival time over chemotherapy

In a key clinical trial, patients receiving the drug achieved a median overall survival of 13.2 months, compared to 6.7 months for patients offered standard chemotherapy.

NYTIMES (Gina Kolata and Rebecca Robbins) - F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

YOUTUBE (MS NOW) - The Night Light: A new hope for cancer patients

Personalized vaccines could be around the corner thanks to decades of work by doctors like Michelle Wu. Her story and details on the new breakthrough on tonight's 11th Hour with Ali Velshi.

HUFFPOST - Moderna, Merck mRNA Cancer Vaccine Cuts Recurrence And Spread Of Melanoma

The companies — and others — are testing similar approaches against lung, breast and pancreatic cancers.